In vivo modulation of the firing activity of putative slow- and fast-spiking interneurons in the medial prefrontal cortex by 5-HT3 receptors in 6-hydroxydopamine-induced Parkinsonian rats

Neuroscience

Volumn 169, Issue 3, 2010, Pages 1315-1325

  Gui, Z H ^a   Zhang, Q J ^a   Liu, J ^a   Ali, U ^a   Li, L B ^a   Wang, Y ^a   Wang, T ^a   Chen, L ^a   Hou, C ^a   Fan, L L ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Electrophysiology; Interneurons; Medial prefrontal cortex; Parkinson's disease

Indexed keywords

BICUCULLINE; SEROTONIN 3 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; ELECTROPHYSIOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTERNEURON; MALE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REFRACTORY PERIOD; SUBSTANTIA NIGRA;

EID: 77955282389     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.05.059     Document Type: Article

References (70)

1. Abi-Dargham A., Laruelle M., Aghajanian G.K., Charney D., Krystal J. The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatry Clin Neurosci 1997, 9:1-17.
2. Acsady L., Halasy K., Freund T.F. Calretinin is present in non-pyramidal cells of the rat hippocampus. III. Their inputs from the median raphe and medial septal nuclei. Neuroscience 1993, 52:829-841.
3. Almeida J.D., Mengod G. Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneurons subpopulation: implications for schizophrenia and its treatment. J Neurochem 2008, 107:488-496.
4. Araneda R., Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 1991, 40:399-412.
5. Ashby C.R., Edwards E., Harkins K., Wang R.Y. Characterization of 5-hydroxytryptamine3 receptors in the medial prefrontal cortex: a microiontophoretic study. Eur J Pharmacol 1989, 173:193-196.
6. Ashby C.R., Edwards E., Wang R.Y. Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors. Synapse 1992, 10:7-15.
7. 3-like receptors in the rat medial prefrontal cortex: an electrophysiological study. Brain Res 1991, 550:181-191.
8. Bartho P., Hirase H., Monconduit L., Zugaro M., Harris K.D., Buzsaki G. Characterization of neocortical principal cells and interneurons by network interactions and extracellular features. J Neurophysiol 2004, 92:600-608.
9. Benes F.M., Vincent S.L., Molloy R. Dopamine-immunoreactive axon varicosities form non-random contacts with GABA-immunoreactive neurons of rat medial prefrontal cortex. Synapse 1993, 15:285-295.
10. 2 receptors and serotonergic axons in rat neocortex. Brain Res 1988, 453:315-328.
11. 2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral-cortex. Naunyn Schmiedebergs Arch Pharmacol 1995, 352. 383-290.
12. Breit S., Bouali-Benazzouz R., Benabid A.L., Benazzouz A. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat. Eur J Neurosci 2001, 14:1833-4182.
13. Buhot M.C. Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 1997, 7:243-254.
14. 3 binding sites following a unilateral 6-hydroxydopamine lesion of the medial forebrain bundle in rats. J Neurol Sci 1993, 115:105-110.
15. Constantinidis C., Goldman-Rakic P.S. Correlated discharges among putative pyramidal neurons and interneurons in the primate prefrontal cortex. J Neurophysiol 2002, 88:3487-3497.
16. Davidson R.J., Putnam K.M., Larson C.L. Dysfunction in the neural circuitry of emotion regulation-a possible prelude to violence. Science 2000, 289:591-594.
17. 3 receptors are membrane ion channels. Nature 1989, 339:706-709.
18. Devoto P., Flore G., Saba P., Castelli M.P., Piras A.P., Luesu W., Viaggi M.C., Ennas M.G., Gessa G.L. 6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex. J Neurosci Res 2008, 86:1647-1658.
19. Dubovsky S.L., Thomas M. Serotonergic mechanisms and current and future psychiatric practice. J Clin Psychiatry 1995, 56(Suppl 2):38-48.
20. Fedrowitz M., Lindemann S., Loscher W., Gernert M. Altered spontaneous discharge rate and pattern of basal ganglia output neurons in the circling (ci2) rat mutant. Neuroscience 2003, 118:867-878.
21. 3 receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide/cholecystokinin interneurons. J Neurosci 2002, 22:7389-7397.
22. Foehring R.C., van Brederode J.F.M., Kinney G.A., Spain W.J. Serotonergic modulation of supragranular neurons in rat sensorimotor cortex. J Neurosci 2002, 22:8238-8250.
23. 1A receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys. Synapse 2001, 39:288-296.
24. Freund T.F. GABAergic septal and serotonergic median raphe afferents preferentially innervate inhibitory interneurons in the hippocampus and dentate gyrus. Epilepsy Res Suppl 1992, 7:79-91.
25. Freund T.F. Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trends Neurosci 2003, 26:489-495.
26. 2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur J Neurosci 1995, 7:1050-1063.
27. Gorelova N., Seamans J.K., Yang C.R. Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J Neurophysiol 2002, 88:3150-3166.
28. 7 receptor in rat brain. Br J Pharmacol 1996, 117:657-666.
29. Hornung J.P., Celio M.R. The selective innervation by serotoninergic axons of calbindin-containing interneurons in the neocortex and hippocampus of the marmoset. J Comp Neurol 1992, 320:457-467.
30. Kawaguchi Y., Kubota Y. Correlation of physiological subgroupings of nonpyramidal cells with parvalbumin-immunoreactive and calbindin(D28k)-immunoreactive neurons in layer-V of rat frontal cortex. J Neurophysiol 1993, 70:387-396.
31. Kawaguchi Y., Kubota Y. GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb Cortex 1997, 7:476-486.
32. 2 dopamine receptor subtypes. Mol Brain Res 1998, 58:231-236.
33. Lidov H.G.W., Grzanna R., Molliver M.E. The serotonin innervation of the cerebral cortex in the rat: an immunohistochemical analysis. Neuroscience 1980, 5:207-227.
34. Lohle M., Storch A., Reichmann H. Beyond tremor and rigidity: non-motor features of Parkinson's disease. J Neural Transm 2009, 116:1483-1492.
35. Manji H.K., Drevets W.C., Charney D.S. The cellular neurobiology of depression. Nat Med 2001, 7:541-547.
36. 3 receptor, a serotonin-gated ion channel. Science 1991, 254:432-437.
37. Markram H., Toledo-Rodriguez M., Wang Y., Gupta A., Silberberg G., Wu C.Z. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 2004, 5:793-807.
38. Miller E.K., Cohen J.D. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001, 24:167-202.
39. Monfort J.C., Javoyagid F., Hauw J.J., Dubois B., Agid Y. Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. Brain 1985, 108:301-313.
40. 3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J Neurosci 1997, 17:3157-3167.
41. Morales M., Battenberg E., deLecea L., Bloom F.E. The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus. Brain Res 1996, 731:199-202.
42. Nayyar T., Bubser M., Ferguson M.C., Neely M.D., Goodwin J.S., Montine T.J., Deutch A.Y., Ansah T.A. Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation. Eur J Neurosci 2009, 30:207-216.
43. A receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease. Jpn J Pharmacol 1988, 48:331-339.
44. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Academic Press, New York, NY. 5th ed.
45. 3 receptors in neuronal cell lines. Trends Pharmacol Sci 1989, 10:172-174.
46. Povysheva N.V., Zaitsev A.V., Rotaru D.C., Gonzalez-Burgos G., Lewis D.A., Krimer L.S. Parvalbumin-positive basket interneurons in monkey and rat prefrontal cortex. J Neurophysiol 2008, 100:2348-2360.
47. 3 receptors. Cereb Cortex 2004, 14:1365-1375.
48. Puig M.V., Ushimaru M., Kawaguchi Y. Two distinct activity patterns of fast-spiking interneurons during neocortical UP states. Proc Natl Acad Sci U S A 2008, 108:8428-8433.
49. 2A receptors. J Neurosci 2010, 30:2211-2222.
50. 3 receptors in developing visual cortex. J Neurosci 1997, 17:8353-8362.
51. Santana N., Bortolozzi A., Serrats J., Mengod G., Artigas F. Expression of serotonin-1A and serotonin-2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 2004, 14:1100-1109.
52. Scholtissen B., Verhey F.R., Steinbusch H.W., Leentjens A.F. Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data. J Neural Transm 2006, 113:59-73.
53. Seamans J.K., Gorelova N., Durstewitz D., Yang C.R. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 2001, 21:3628-3638.
54. Sesack S.R., Snyder C.L., Lewis D.A. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol 1995, 363:264-280.
55. Shulman L.M., Taback R.L., Bean J., Weiner W.J. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001, 16:507-510.
56. Smiley J.F., Goldman-Rakic P.S. Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy. J Comp Neurol 1996, 367:431-443.
57. Steinbusch H.W.M. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 1981, 6:557-618.
58. Stockmeier C.A. Neurobiology of serotonin in depression and suicide. Ann N Y Acad Sci 1997, 836:220-232.
59. Swanson L.W. Brain maps: structure of the rat brain 1998, Elsevier, Amsterdam.
60. Tseng K.Y., Mallet N., Toreson K.L., Le Moine C., Gonon F., O'Donnell P. Excitatory response of prefrontal cortical fast-spiking interneurons to ventral tegmental area stimulation in vivo. Synapse 2006, 59:412-417.
61. Verney C., Alvarez C., Geffard M., Berger B. Ultrastructural double labelling study of dopamine terminals and GABA-containing neurons in rat anteromedial cerebral cortex. Eur J Neurosci 1990, 2:295-298.
62. 2 receptors in rat medial prefrontal cortex. J Neurosci 1993, 13:2551-2564.
63. 2 receptors in rat medial prefrontal cortex. Synapse 1995, 19:112-120.
64. 2A/2C receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease. Exp Neurol 2009, 219:239-248.
65. Wang S., Zhang Q.J., Liu J., Wu Z.H., Ali U., Wang Y., Chen L., Gui Z.H. The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine1A receptor stimulation in a rat model of Parkinson's disease. Neuroscience 2009, 162:1091-1100.
66. 1A receptor stimulation in the rat. Neuroscience 2009, 159:850-861.
67. 2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats. Brain Res 2005, 1045:229-233.
68. 2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model. Physiol Behav 2007, 92:29-33.
69. Zhou F.M., Hablitz J.J. Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 1999, 82:2989-2999.
70. Ziemssen T., Reichmann H. Non-motor dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2007, 13:323-332.